Scalp Care Efficacy Evaluation for Premium Revitalizing Elixir

The study aims to evaluate the efficacy of the Premium Revitalizing Elixir on human scalp skin. A total of 60 healthy adults, aged 18 to 60 with alopecia, baldness, or self-identified with symptoms of hair thinning will be recruited and randomly assigned into five groups receiving different formulations. Participants will use the product once daily for 56 days, and their scalp conditions will be assessed through skin texture tests at multiple time points. Key parameters such as sebum content, overall hair loss, hair density, scalp condition, and hair length will be measured. A self-assessment and assessment by a hair specialist on hair and scalp condition will also be provided at the end of the study (Day 56).

Inclusion Criteria: * Healthy adults of any gender from the age of 18 to 60 years (inclusive). * Having symptoms of alopecia, baldness, or self-identified with hair thinning. * Absence of chronic diseases, major illnesses, or allergies. * Major illnesses include cancer, post-stroke disorders, paralysis, acute myocardial infarction, coronary artery bypass surgery, end-stage renal disease, and major organ transplant or hematopoietic stem cell transplant Exclusion Criteria: * Currently taking any medication or using any scalp care products * Pregnant or breastfeeding * Chronic diseases, significant illnesses, or allergic constitutions * Currently using scalp care products * Students or employees affiliated with the principal investigator, * Individuals with scalp wounds * Participated in cosmetic product testing * Undergone scalp aesthetic treatments within the past three months.